dc.contributor.author | CORVIN, AIDEN | en |
dc.contributor.author | DONOHOE, GARY | en |
dc.date.accessioned | 2016-09-23T12:55:29Z | |
dc.date.available | 2016-09-23T12:55:29Z | |
dc.date.issued | 2015 | en |
dc.date.submitted | 2015 | en |
dc.identifier.citation | Patel, V.S., Kelly, S., Wright, C., Gupta, C.N., Arias-Vasquez, A., Perrone-Bizzozero, N., Ehrlich, S., Wang, L., Bustillo, J.R., Morris, D., Corvin, A., Cannon, D.M., McDonald, C., Donohoe, G., Calhoun, V.D., Turner, J.A., MIR137HG risk variant rs1625579 genotype is related to corpus callosum volume in schizophrenia, Neuroscience Letters, 602, 2015, 44-49 | en |
dc.identifier.other | Y | en |
dc.description | PUBLISHED | en |
dc.description.abstract | Genome-wide association studies implicate the MIR137HG risk variant rs1625579 (MIR137HGrv) within the host gene for microRNA-137 as a potential regulator of schizophrenia susceptibility. We examined the influence of MIR137HGrv genotype on 17 subcortical and callosal volumes in a large sample of individuals with schizophrenia and healthy controls (n=841). Although the volumes were overall reduced relative to healthy controls, for individuals with schizophrenia the homozygous MIR137HGrv risk genotype was associated with attenuated reduction of mid-posterior corpus callosum volume (p=0.001), along with trend-level effects in the adjacent central and posterior corpus callosum. These findings are unique in the literature and remain robust after analysis in ethnically homogenous and single-scanner subsets of the larger sample. Thus, our study suggests that the mechanisms whereby MIR137HGrv works to increase schizophrenia risk are not those that generate the corpus callosum volume reductions commonly found in the disorder. | en |
dc.description.sponsorship | The authors gratefully acknowledge Jill Fries for her assistance with executing the FreeSurfer segmentation on the COBRE1, COBRE2, MCIC, and NU datasets. We also thank Dr. Ronald Yeo for his guidance with the early development of this manuscript.
This work was supported by the National Institutes of Health (grant numbers 5R01MH094524-03 to VDC and JAT, R01MH084898-01A1 to JRB, P50 MH071616, R01MH056584, 1R01 MH084803 to LW, and 1U01 MH097435 to LW and JAT); the United States Department of Energy (grant number DE-FG02-99ER62764); the Science Foundation Ireland (grand number SFI 12.IP.1359); the Irish Health Research Board (grant numbers HRA_POR/2011/100, HRA_POR/2012/54); and the Wellcome Trust (grant number 072894/2/03/Z). | en |
dc.format.extent | 44-49 | en |
dc.relation.ispartofseries | Neuroscience Letters | en |
dc.relation.ispartofseries | 602 | en |
dc.rights | Y | en |
dc.subject | microRNA-137, MIR137, schizophrenia, subcortical volume, corpus callosum, multi-site | en |
dc.subject.lcsh | microRNA-137, MIR137, schizophrenia, subcortical volume, corpus callosum, multi-site | en |
dc.title | MIR137HG risk variant rs1625579 genotype is related to corpus callosum volume in schizophrenia | en |
dc.type | Journal Article | en |
dc.type.supercollection | scholarly_publications | en |
dc.type.supercollection | refereed_publications | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/acorvin | en |
dc.identifier.peoplefinderurl | http://people.tcd.ie/donoghug | en |
dc.identifier.rssinternalid | 111410 | en |
dc.identifier.doi | http://dx.doi.org/10.1016/j.neulet.2015.06.039 | en |
dc.rights.ecaccessrights | openAccess | |
dc.identifier.orcid_id | 0000-0001-6717-4089 | en |
dc.contributor.sponsor | Science Foundation Ireland (SFI) | en |
dc.contributor.sponsorGrantNumber | SFI 12.IP.1359 | en |
dc.identifier.uri | http://hdl.handle.net/2262/77414 | |